Showing results (371-380 of 422) with videos related to
Sort By:
Pageof 43
British Journal of Haematology|November 28, 2024
Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single-arm FIL-BRB trialGiulia Benevolo, Daniela Drandi, Nicoletta Villivà, et al.Seminars in Hematology|May 16, 2025
Report of Consensus Panel 5 from the 12th International Workshop on Waldenström's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitorsJorge J Castillo, Francesco Autore, Neil L Berinstein, et al.Scientific Reports|December 11, 2021
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematologyGian Maria Zaccaria, Vito Colella, Simona Colucci, et al.Blood|July 12, 2019
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 studyStefano Luminari, Michele Merli, Sara Rattotti, et al.Hematological Oncology|August 21, 2020
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphomaIrene Della Starza, Lucia Anna De Novi, Marzia Cavalli, et al.Scientific Reports|July 23, 2024
Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trialMichele Clerico, Simone Ferrero, Beatrice Alessandria, et al.The Lancet. Haematology|December 9, 2016
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana LinfomiCarlo Visco, Annalisa Chiappella, Luca Nassi, et al.Blood|June 23, 2022
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphomaSimone Ferrero, Daniele Grimaldi, Elisa Genuardi, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 23, 2021
Factors predicting morbidity in surgically-staged high-risk endometrial cancer patientsGiorgio Bogani, Andrea Papadia, Alessandro Buda, et al.Blood|December 19, 2013
A targeted mutational landscape of angioimmunoblastic T-cell lymphomaOreofe Odejide, Oliver Weigert, Andrew A Lane, et al.Pageof 43